Movement disorders: Repurposing riluzole to treat hereditary cerebellar ataxia
- PMID: 26369510
- DOI: 10.1038/nrneurol.2015.161
Movement disorders: Repurposing riluzole to treat hereditary cerebellar ataxia
Comment on
- 
  
  Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial.Lancet Neurol. 2015 Oct;14(10):985-91. doi: 10.1016/S1474-4422(15)00201-X. Epub 2015 Aug 25. Lancet Neurol. 2015. PMID: 26321318 Clinical Trial.
References
- 
    - Lancet Neurol. 2015 Oct;14(10):985-91 - PubMed
 
Publication types
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Medical
 
        